This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

7 Feb 2013

Clinical trial underway for the treatment of traumatic brain injuries

A clinical trial is underway to see if Oxycyte is safer and tolerable in patients with severe non-penetrating traumatic brain injury.


Oxygen Biotherapeutics has today revealed that it has enrolled the first participant to its Phas II clinical trial of Oxycyte, as it seeks to gauge the effectiveness of this in relation to those with severe non-penetrating traumatic brain injury (STOP-TBI).

Related News